Related references
Note: Only part of the references are listed.Pitfalls in case-control studies of vaccine effectiveness
Matthew R. Moore et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pitfalls in case-control studies of vaccine effectiveness - Reply
Aurelio Barricarte et al.
CLINICAL INFECTIOUS DISEASES (2007)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004
Lauri A. Hicks et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children
Michael E. Pichichero et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine
Ricardo Dias et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Childhood pneumonia mortality - a permanent global emergency
Kim Mulholland
LANCET (2007)
Changing characteristics of invasive pneumococcal disease in metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine
W. C. Albrich et al.
CLINICAL INFECTIOUS DISEASES (2007)
Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine
Stephen I. Pelton et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Effectiveness of the 7-valent pneumococcal conjugate vaccine: A population-based case-control study
Aurelio Barricarte et al.
CLINICAL INFECTIOUS DISEASES (2007)
Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005
Allison F. Messina et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
Rosalyn J. Singleton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae
In Ho Park et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
The preventable burden of pneumococcal disease in the developing world
J. A. G. Scott
VACCINE (2007)
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era
William P. Hanage et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers
Philip C. Hill et al.
CLINICAL INFECTIOUS DISEASES (2006)
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae:: An explanation of trends in invasive pneumococcal disease
LL Hammitt et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
MH Kyaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002
B Beall et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes
Stephen D. Bentley et al.
PLOS GENETICS (2006)
Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?
SK Obaro et al.
LANCET INFECTIOUS DISEASES (2006)
Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization
B Flannery et al.
ANNALS OF INTERNAL MEDICINE (2006)
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States
R Pai et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity
TW Hennessy et al.
VACCINE (2005)
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
CA Lexau et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004
SS Huang et al.
PEDIATRICS (2005)
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West:: Emergence of nonvaccine serogroups
CL Byington et al.
CLINICAL INFECTIOUS DISEASES (2005)
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
FT Cutts et al.
LANCET (2005)
Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland
WP Hanage et al.
INFECTION AND IMMUNITY (2005)
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine
SL Kaplan et al.
PEDIATRICS (2004)
Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life
F Ghaffar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae
K Trzcinski et al.
JOURNAL OF BACTERIOLOGY (2004)
Ability of pneumococcal serotypes and clones to cause acute otitis media: Implications for the prevention of otitis media by conjugate vaccines
WP Hanage et al.
INFECTION AND IMMUNITY (2004)
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities -: Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates
SI Pelton et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children
AB Brueggemann et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection
KP Klugman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential
AB Brueggemann et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: Randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children
T Kilpi et al.
CLINICAL INFECTIOUS DISEASES (2003)
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States
B Beall et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Multilocus sequence typing of Streptococcus pneumoniae clones with unusual drug resistance patterns:: Genetic backgrounds and relatedness to other epidemic clones
R Sá-Leao et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Efficacy of a pneumococcal conjugate vaccine against acute otitis media
J Eskola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae:: Alaska, 1991-1998
KM Rudolph et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Direct expenditures related to otitis media diagnoses: Extrapolations from a pediatric medicaid cohort
J Bondy et al.
PEDIATRICS (2000)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I
WP Hausdorff et al.
CLINICAL INFECTIOUS DISEASES (2000)
The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II
WP Hausdorff et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
